Zentalis Pharmaceuticals Llc (ZNTL) — Financial Flexibility Index
Zentalis Pharmaceuticals Llc (ZNTL) has a Financial Flexibility Index of -0.43x as of December 2025. Free cash flow of $-30.94 Million (operating CF $-30.94 Million minus capex $0.00) represents 0% of total liabilities ($72.76 Million). Check how strategically is Zentalis Pharmaceuticals Llc's equity deployed to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Zentalis Pharmaceuticals Llc Financial Flexibility Index (2018–2025)
Historical Financial Flexibility Index trend for Zentalis Pharmaceuticals Llc across 8 annual periods. See working capital position of Zentalis Pharmaceuticals Llc to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Zentalis Pharmaceuticals Llc (2018–2025)
Year-by-year free cash flow to debt coverage for Zentalis Pharmaceuticals Llc. For the full company profile including market capitalisation, see Zentalis Pharmaceuticals Llc market capitalisation.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -1.72x | $-125.25 Million | $-125.25 Million | $72.76 Million | ▲ +6.0% |
| 2024 | -1.83x | $-170.64 Million | $-170.86 Million | $93.15 Million | ▼ -10.2% |
| 2023 | -1.66x | $-207.24 Million | $-207.82 Million | $124.64 Million | ▼ -23.2% |
| 2022 | -1.35x | $-161.20 Million | $-163.75 Million | $119.43 Million | ▲ +1.9% |
| 2021 | -1.38x | $-147.99 Million | $-154.09 Million | $107.54 Million | ▲ +48.6% |
| 2020 | -2.67x | $-86.07 Million | $-86.83 Million | $32.18 Million | ▼ -36.6% |
| 2019 | -1.96x | $-38.79 Million | $-39.14 Million | $19.81 Million | ▲ +29.2% |
| 2018 | -2.76x | $-24.02 Million | $-24.25 Million | $8.69 Million | — |